For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

Chronic Kidney Disease (CKD) is a widespread and frequently under recognised condition impacting millions around the globe.

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...